Kostas Zervas

938 citations
14 papers · 669 indexed · h-index 10
Topics
Multiple Myeloma Research and Treatments (10 papers)Bone health and treatments (4 papers)Peptidase Inhibition and Analysis (4 papers)

In The Last Decade

Kostas Zervas

14 papers receiving 650 citations

Peers

Kostas Zervas
Comparison fields: 5 of 41
  • Oncology 512
  • Hematology 353
  • Orthopedics and Sports Medicine 225
  • Molecular Biology 148
  • Genetics 78
Replace Konstantinos Tsionos with:
Konstantinos Tsionos Greece
Evangelos Eleftherakis-Papaiakovou Greece
Francesco Pietrogrande Italy
Richard Leff United States
Edgardo Angtuaco United States
Vassiliki Koutsoukou Greece
Aref Chehal Lebanon
Ioannis Melakopoulos Greece
Kyoko Haraguchi Japan
Leo V. Lacerna United States
Kostas Zervas relative to Konstantinos Tsionos Greece Konstantinos Tsionos's profile →
Citations per field
00.5×1.5×1.8×
Konstantinos Tsionos · 1×
Citations per year

Countries citing papers authored by Kostas Zervas

Since Specialization
Citations

This map shows the geographic impact of Kostas Zervas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kostas Zervas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kostas Zervas more than expected).

Fields of papers citing papers by Kostas Zervas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kostas Zervas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kostas Zervas. The network helps show where Kostas Zervas may publish in the future.

Co-authorship network of co-authors of Kostas Zervas

This figure shows the co-authorship network connecting the top 25 collaborators of Kostas Zervas. A scholar is included among the top collaborators of Kostas Zervas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kostas Zervas. Kostas Zervas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 43
2 32
3 114
4 1
5 1
6 13
7 212
8 23
9 170
10 11
11 3
12 7
13 17
14 22

About Kostas Zervas

Kostas Zervas is a scholar working on Hematology, Oncology and Pharmacy, having authored 14 papers that have together received 669 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (10 papers), Bone health and treatments (4 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Hematology (353 citations), Orthopedics and Sports Medicine (225 citations) and Oncology (512 citations). Kostas Zervas has collaborated with scholars based in Greece, United Kingdom and France. Frequent co-authors include Evgenia Verrou, Evangelos Terpos, Eirini Katodritou, Dimitra Mihou, Anastasia Banti, Meletios Α. Dimopoulos, Konstantinos Vahtsevanos, Anastasia Pouli, Andrew Chantry and Amin Rahemtulla. Their work appears in journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026